Connection

PAUL LING to Virus Latency

This is a "connection" page, showing publications PAUL LING has written about Virus Latency.
Connection Strength

0.673
  1. Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells. J Virol. 2013 Nov; 87(22):12151-7.
    View in: PubMed
    Score: 0.426
  2. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
    View in: PubMed
    Score: 0.094
  3. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio. 2019 09 17; 10(5).
    View in: PubMed
    Score: 0.040
  4. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J Virol. 1999 Jan; 73(1):826-33.
    View in: PubMed
    Score: 0.039
  5. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol. 1995 Nov; 15(11):6150-9.
    View in: PubMed
    Score: 0.031
  6. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
    View in: PubMed
    Score: 0.029
  7. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol. 2004 Nov; 78(22):12694-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.